RxDoctor Payments Data

Dilip Kamath, MD

Anesthesiology · Miami, FLNPI 1023549714

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Abbott at 53.5% of the total. Reporting peaked in 2023 at $6,079 and has fallen 86.4% since, to $824 in 2025. Among anesthesiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,807in general payments, 2019–2025

Across 144 payments — averaging $68.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Medtronic$2K
  • Boston Scientific$788
  • SPR Therapeutics, Inc$444
  • Nalu Medical, Inc.$397
  • Nevro Corp.$146
  • plus $535 from 11 others

What the payments were for

  • Travel & lodging$4,24243%
  • Food & beverage$5,52756%
  • Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,807 in reported general payments places this provider in the 95th percentile of 2,767 anesthesiology providers in Florida.

See all anesthesiology providers in Florida →

Medicare billing

Part B allowed, 2024
$493,360
Medicare patients
323
Services billed
5,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine26$2,682
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen162$2,658
Gabapentin275$2,485
Lidocaine29$1,838
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen100$1,486
Tizanidine Hcl121$1,426
Pregabalin70$1,420
Celecoxib57$965
Cyclobenzaprine Hcl129$926
Tramadol Hcl161$903
Duloxetine Hcl105$755
Oxycodone Hcl39$397
Baclofen18$291
Meloxicam68$284
Diclofenac Sodium12$282

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →